Clinical trial
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce…
NCT00115648 · Johns Hopkins Bloomberg School of Public Health, Other · Completed
Key facts
| NCT number | NCT00115648 |
|---|---|
| Title | Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission |
| Official title | Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission |
| Lead sponsor | Johns Hopkins Bloomberg School of Public Health, Other |
| Collaborators | Centers for Disease Control and Prevention U.S. Fed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Nevirapine, AZT, NVP and AZT, NVP, NVP+AZT |
| Enrollment | 3,300 |
| Start date | Apr 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Oct 1, 2009 |
| First posted | Jun 24, 2005 |
| Last update posted | Mar 7, 2014 |
| Countries | Malawi |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: